
Canadian pro healthy, playing competitive golf again after scary on-course accident
Article content
Thibault's hands instinctively flew to the back of her head as she lost consciousness and sank to the ground.
Article content
Article content
'I remember the vibration because it was so loud in my head,' recalled Thibault on Tuesday. 'I remember thinking, 'what the hell just hit me?'
Article content
Article content
'Then I opened my eyes and I was on the ground. I remember looking at both of my hands and they were just full of red blood.'
Article content
The 26-year-old from Rosemere, Que., was rushed to hospital where she was diagnosed with a concussion. The doctors also told her that she was 'lucky' that the blood was flowing outwards and that there was no serious internal bleeding.
Article content
Indeed, she didn't even need any stitches.
Article content
Thibault said she basically slept non-stop for the next two weeks and then returned to the gym to build her strength back up. But the damage the accident did to her nervous system and the lingering post-traumatic stress disorder have been harder to shake.
Article content
'For like a week and a half to two weeks, I was waking up because I would re-feel the vibration or see the hands (covered in blood),' said Thibault. 'It's strange to explain.'
Article content
Even as she physically recovered and the nightmares faded, PTSD episodes continued to surprise Thibault for weeks after the incident.
Article content
'A dog barks or a baby would cry, it would trigger a whole panic attack, as if I was getting attacked,' said Thibault, noting she hasn't had any episodes since the first week of February. 'I'll feel like there's going to be a panic attack, but then I don't start crying or anything more.
Article content
Article content
'When the accident happened, I was so caught off guard (…) that anything that would catch me off guard, post that event, would alarm my whole nervous system.'
Article content
Determined to return to her career, Thibault resumed playing competitive golf in March with her first event of 2025 sponsored by the same company as the fateful mini-tour event, also in the Orlando area.
Article content
'I was driving to the course, and I started crying, because I was just like, 'this feels too much the same,'' she said. 'It's strange to explain.
Article content
'I mean, I still don't know if something's gonna pop out, but for now, I feel pretty much back to my normal self.'
Article content
Thibault is now playing on the Epson Tour, the feeder circuit for the top-flight LPGA Tour, and has appeared in six events so far this year. Although she hasn't gotten the results she'd like, missing the cut in her past five tournaments, she feels like her game is close.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Globe and Mail
an hour ago
- Globe and Mail
Why Novo Nordisk Stock Bumped Higher on Friday
Key Points The Federal government might boost its support of weight-loss drugs soon. According to a media report, it's contemplating a five-year, experimental program that would subsidize their costs for qualifying patients. 10 stocks we like better than Novo Nordisk › Unexpected news of a potential support program from the federal government boosted the share prices of weight-loss drug developers on Friday. The poster boy for that still rather small group, Wegovy/Ozempic maker Novo Nordisk (NYSE: NVO), understandably saw a stock price lift that day. It rose by more than 2%, contrasting well with the 1.6% slide of the S&P 500 index. Federal help for obesity drugs? That news came from The Washington Post, which published an article stating that the Trump administration is planning an experimental program that would cover the costs of such medications. Citing documents from the Centers for Medicare and Medicaid Services (CMS) it had obtained, the newspaper said the plan would be implemented by state Medicaid administrations. It would also be utilized by Medicare Part D insurance plans. These entities would be allowed to cover weight-loss drugs for qualifying patients. At the moment, Medicare generally covers such treatments for patients who suffer from type 2 diabetes. Both Novo Nordisk's Wegovy and rival Eli Lilly 's Zepbound are essentially versions of predecessor diabetes drugs. Some private insurance plans cover obesity medications. The Post wrote that the experimental program will last for five years. Massive potential impact Novo Nordisk hasn't yet commented on the article, but we can be sure the company is excited about the prospect. Combined, Medicare and Medicaid are immense programs. Even if only a few states are willing to cover weight-loss treatments through them, the company could experience a surge in sales. For the stock's investors, this is a potentially very impactful development well worth monitoring. Should you invest $1,000 in Novo Nordisk right now? Before you buy stock in Novo Nordisk, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Novo Nordisk wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $625,254!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,090,257!* Now, it's worth noting Stock Advisor's total average return is 1,036% — a market-crushing outperformance compared to 181% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025


CTV News
2 hours ago
- CTV News
Liberal U.S. states sue Trump over transgender care ban
The Pride flag seen at Windsor, Ont. on Aug. 1, 2025. (Gary Archibald/CTV News Windsor) A coalition of liberal U.S. states on Friday said it was suing U.S. President Donald Trump's administration over an order to prevent clinics providing gender-affirming care to children. The lawsuit, brought by officials from California and 15 other states, as well as the District of Columbia, challenges an executive order that denounces the treatment as 'chemical and surgical mutilation.' The order, which Trump signed in January, calls on the U.S. Department of Justice (DoJ) to investigate providers who offer such treatment, even in states where it is legal. 'The President and his Administration's relentless attacks on gender-affirming care endanger already vulnerable adolescents whose health and well-being are at risk,' California's Attorney General Rob Bonta said. 'Their demands that our healthcare providers discriminate against transgender individuals and deny them access to medically-necessary healthcare is cruel and irresponsible.' The DoJ said last month it had issued more than 20 subpoenas to doctors and clinics providing treatment to adolescents. U.S. Attorney General Pam Bondi said at the time that 'medical professionals and organizations that mutilated children in the service of a warped ideology will be held accountable.' The lawsuit, filed in a U.S. District Court in Massachusetts, argues that the administration's actions have no legal basis and should be declared unlawful. 'These actions have created a chilling effect in which providers are pressured to scale back on their care for fear of prosecution, leaving countless individuals without the critical care they need and are entitled to under law,' said Bonta. LGBTQ+ rights have become a divisive subject in the United States, where Trump rode a wave of public support for his crusade against so-called 'woke ideology.' In his first days in office, Trump declared the federal government would recognize only two genders -- men and women -- and has targeted transgender people in a slew of other orders. In February, he issued an executive order aimed at banning transgender athletes, allowing federal agencies to halt funding to any institution that does not consider birth-assigned genders in determining sex. The lawsuit groups California with New York, Massachusetts, Illinois, Connecticut, Delaware, Hawaii, Maine, Maryland, Michigan, Nevada, New Jersey, New Mexico, Rhode Island, Wisconsin, Pennsylvania and the District of Columbia. It is the latest legal effort from a coalition of Democratic-run states aimed at pushing back at what liberals see as overreach by the Trump presidency.


Globe and Mail
4 hours ago
- Globe and Mail
Shaping the Future of Medicine: Dr. Guy Navarra Launches Scholarship for Aspiring Physicians
Shaping the Future of Medicine: Dr. Guy Navarra Launches Scholarship for Aspiring Physicians Newburyport, Massachusetts - Undergraduate students with dreams of becoming doctors now have a new opportunity to jumpstart their journey, thanks to the launch of the Dr. Guy Navarra Scholarship for Future Doctors. This $1,000 scholarship recognizes and supports one outstanding student preparing to enter the medical field—someone whose vision, heart, and dedication echo the values of its founder, Dr. Guy Navarra. The scholarship, now accepting applications, is designed for U.S.-based undergraduate students pursuing careers in medicine, pre-medical studies, or related health sciences. With the growing need for committed, forward-thinking professionals in healthcare, Dr. Guy Navarra aims to reward a student who not only excels academically but also holds a strong purpose for making an impact in tomorrow's healthcare system. To apply, students must submit a personal essay (500–800 words) in response to the following prompt: 'What inspires your journey into medicine, and how do you envision making a meaningful impact on the healthcare system of tomorrow?' Essays will be judged on clarity, authenticity, creativity, and alignment with the mission of Dr. Navarra's scholarship: to cultivate leadership, empathy, and transformation in the next generation of doctors. Dr. Guy Navarra brings a wealth of knowledge and inspiration to this initiative. With over 25 years of experience in internal medicine, geriatrics, and obesity medicine, he has held roles in clinical care, academic research, hospital leadership, and executive strategy. A graduate of Madrid's Complutense University, and later Yale and Harvard, Dr. Guy Navarra exemplifies what it means to blend global education with patient-centered care. His commitment to preventative medicine and ethical innovation has shaped programs, improved lives, and helped bridge gaps in the healthcare system. Currently serving as primary care physician for the Greater Newburyport area and Chief Medical Officer for MetTrimMD, Dr. Guy Navarra continues to lead by example—pioneering patient-first approaches to metabolic health and chronic disease management. Through this scholarship, he now turns his focus to supporting students who are following in his footsteps. 'The future of medicine depends not just on knowledge, but on heart and vision,' says Dr. Guy Navarra. 'This scholarship is a way to honor students who are already showing signs of leadership, passion, and the ability to think critically about where healthcare is headed.' Interested students should email their essay submission along with basic academic details—name, major, university, expected graduation year, and a short bio—to apply@ The deadline to apply is April 15, 2026, and the scholarship recipient will be publicly announced on May 15, 2026. The $1,000 award can be applied toward tuition, educational supplies, or other school-related expenses. It's not just a financial boost—it's a mark of recognition from a physician who believes deeply in mentoring the leaders of tomorrow. To learn more, visit the official scholarship site at Media Contact Company Name: Dr. Guy Navarra Scholarship Contact Person: Dr. Guy Navarra Email: Send Email City: Newburyport State: Massachusetts Country: United States Website: